The Digital Health Update by Paul Sonnier ⋅ Nov 26, 2016 ⋅ #249

The Digital Health Update by Paul Sonnier ⋅ Nov 26, 2016 ⋅ #249

I made this announcement to 52,236 members of the Digital Health group on LinkedIn. If you’re on LinkedIn, please do join the group, which allows you to opt in to receiving these announcements in addition to connecting with thousands of other global stakeholders in digital health. Note that I will continue to update this announcement up until sending out the final version via LinkedIn. The Digital Health Update by Paul Sonnier ⋅ Nov 26, 2016 ⋅ #249 Dear Group, San Diego-based lab-on-a-chip single-blood-drop testing startup Genalyte has raised a $36M equity funding round led by Vinod Khosla’s Khosla Ventures and the Redmile Group. Unlike Theranos, Genalyte has taken the more traditional medical innovation path vis-à-vis transparency and technology validation: They were started by people with a medical background, are working closely with the medical community, and have published in scientific journals. The company plans to conduct clinical studies to validate the accuracy of its finger prick technology against whole blood testing techniques plus run more clinical trials leading to regulatory approval for use in point-of-care settings and, apparently, for the DTC market. Speaking of diagnostic testing solutions, Quest Diagnostics is expanding upon its direct-to-consumer lab tests through its MyQuest app. Customers in Colorado and Missouri will be able to see some of their test results via the app. Plans by Novartis’ Alcon unit and Alphabet’s Verily to begin human testing of an autofocus contact lens for people with presbyopia, or farsightedness, have been postponed until next year. It’s unclear (no pun intended) if testing of the glucose-sensing lenses also being developed by the two companies is delayed as well. As recently as...
The Digital Health Update by Paul Sonnier ⋅ Nov 19, 2016 ⋅ #248

The Digital Health Update by Paul Sonnier ⋅ Nov 19, 2016 ⋅ #248

I made this announcement to 52,105 members of the Digital Health group on LinkedIn. If you’re on LinkedIn, please do join the group, which allows you to opt in to receiving these announcements in addition to connecting with thousands of other global stakeholders in digital health. Note that I will continue to update this announcement up until sending out the final version via LinkedIn. The Digital Health Update by Paul Sonnier ⋅ Nov 19, 2016 ⋅ #248 Dear Group, Pfizer is sponsoring the “Advancing Care for Patients Living with Metastatic Breast Cancer (mBC)” challenge, in collaboration with Health 2.0, to encourage innovators to harness technology & develop cutting edge solutions that will help enrich the lives of patients living with mBC. The challenge is organized into 3 phases with milestones that correlate to successive stages in tech development. The development to beta phase involves mentoring, funding, and support to get to a viable prototype. A total of $250,000 in prize funding will be awarded to tech-enabled solutions with the greatest potential to enrich the lives of patients with mBC. Organizations, developers, entrepreneurs, designers, and innovators are encouraged to submit applications at AdvancingMBCPatientCare.com by January 20, 2017. 2.4 million people downloaded a video game for the world’s largest dementia research experiment. By recording the sense of direction and navigational skills of players moving a virtual sailboat, researchers hope to use the data to develop a dementia test and possibly diagnose Alzheimer’s disease in its earliest stages.  Dr. Hugo Spiers of University College London Spatial Cognition Group told the BBC: “What we’re able to announce to the world is it does decline across the...